Malaysia Reports 55 Dengue Deaths Amid Low Vaccination
A 56% surge in Malaysian dengue cases and 55 deaths are attributed to low vaccine uptake driven by high costs and restrictive clinical eligibility criteria.
Atlas Newsdesk ·
Malaysia has reported 58,079 dengue cases and 55 fatalities this year, representing a 56.2% increase in infection rates. Despite the surge, public uptake of the dengue vaccine remains low, hindering efforts to mitigate the outbreak.
Financial barriers are identified as the primary driver for low vaccination rates. The two-dose regimen costs between 420 and 500 ringgit, significantly exceeding the price of alternative immunizations such as the flu vaccine.
Clinical guidelines further restrict the vaccine's deployment, as it is contraindicated for pregnant women, breastfeeding mothers, and immunocompromised individuals. The vaccine is currently limited to patients aged four to 60, complicating broad-based public health strategies.
Limited publicity at the general practitioner level has further constrained vaccine distribution compared to larger medical facilities. These factors collectively challenge the efficacy of current containment measures against the ongoing epidemiological trend.